The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response
Open accessAbstract
In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Here we show the importance of IL-13 in the pathogenesis of schistosomiasis, and demonstrate, perhaps for the first time, the therapeutic efficacy of an IL-13 inhibitor, sIL-13Ralpha2-Fc, in the control of hepatic fibrosis. T-helper type 2 (Th2) cytokines dominate the immune response in mice infected with Schistosoma mansoni, yet the specific contributions of IL-13 and IL-4 to the development of fibrosis were not previously investigated. Our studies demonstrate that both cytokines play redundant roles in granuloma formation, which explains the ability of IL-4-deficient mice to form granulomas around eggs. More importantly, however, these studies demonstrate that IL-13 is the dominant Th2-type cytokine regulating fibrosis. IL-13 stimulated collagen production in fibroblasts, and procollagen I and procollagen III mRNA expression was decreased in sIL-13Ralpha2-Fc-treated mice. Moreover, the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals. Fibrosis is a major pathological manifestation of a number of allergic, autoimmune, and infectious diseases. Thus, our findings provide evidence that IL-13 inhibitors may be of general therapeutic benefit in preventing damaging tissue fibrosis resulting from Th2-dominated inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617 · cited 2×
“IL-13 was also recently shown to play a central role in murine asthma (30, 31).”
BackgroundSelf-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“Indeed, the targeted pulmonary expression of IL-13 was shown to cause mucus cell metaplasia, airway fibrosis, and nonspecific airway hyperreactivity (43).”
BackgroundStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628 · cited 1×
“In contrast to these observations, granuloma formation and the development of hepatic fibrosis was severely impaired in Stat6-deficient mice (10), which display a major defect in the production of several Th2-associated cytokines (39).”
ResultTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525 · cited 1×
“Specifically, hepatic collagen was measured as hydroxyproline by the technique of Bergman and Loxley after hydrolysis of a 200-mg portion of liver in 5 mL of 6 N HCl at 110°C for 18 hours (35).”
MethodDisruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundPearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., & Sher, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.159 · Cited by 765
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationGrzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citation
Research works printed but not linked: 1
- Bergman, 1963, Anal Biochem, 35, 1961
Cited by
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
“Therapeutic implications and conclusions Studies have begun using antibodies, soluble receptors or chimaeric proteins that regulate the function of IL-13 as potential inhibitors to restrict fibrosis in granuloma formatio”
BackgroundCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
“Indeed, a recent report suggested that TGFβ1-driven pulmonary fibrosis might in some cases be dependent on IL-13-mediated signalling through the IL-13Rα2 chain [100], which was originally thought to operate exclusively as a decoy receptor for IL-13 and as an inhibitor of fibrosis [53,101].”
BackgroundResultInfluentialSelf-citationMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
“72), and although all three have been linked to the development of fibrosis 55,73,74 , IL-13 has emerged as a dominant mediator of fibrotic tissue remodeling in several experimental and natural models of fibrosis 74 .”
Self-citationMacrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
“Outside the context of type 1 and type 2 immune response paradigm macrophages have also been associated with important non pathogen-driven diseases, such as atherosclerosis (61), osteoporosis (62, 63) tissue injury and uncontrolled tissue remodeling (64-66).”
BackgroundFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citation
Metadata
- Authors
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408441
- OpenAlex
- W1975021657
- Cited by
- 603
- References
- 47
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 13 · 2018: 34 · 2017: 18 · 2016: 30 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 30
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-13, liver fibrosis, schistosomiasis, Schistosoma mansoni, Th2 cytokines, IL-4, granuloma formation, collagen synthesis, fibroblasts, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Animals, Female, Liver, Liver Cirrhosis, Experimental, Mice, Inbred C57BL, Procollagen, RNA, Messenger, Schistosomiasis mansoni, Interleukin-4, Cytokines, 3T3 Cells, Mice, Knockout, Th1 Cells, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response. https://app.cochat.ai/papers/10.1172/jci7325
- The paper
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999). An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response. Journal of Clinical Investigation. https://doi.org/10.1172/jci7325
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.